Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications
暂无分享,去创建一个
David T. W. Jones | S. Fröhling | A. Stenzinger | A. von Deimling | W. Hartmann | H. Sinn | D. Stichel | F. Sahm | C. Koelsche | G. Mechtersheimer | A. Banito | F. Kommoss | F. Kommoss | C. Heilig | D. Schmidt | K. Chang
[1] A. Talhouk,et al. DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnostics , 2019, Journal of cancer research and clinical oncology.
[2] S. Lim-Tan,et al. ZC3H7B-BCOR-Rearranged Endometrial Stromal Sarcomas: A Distinct Subset Merits its Own Classification? , 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[3] M. Ladanyi,et al. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas , 2018, The American journal of surgical pathology.
[4] Cheng-Han Lee,et al. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. , 2017, Pathology.
[5] J. Fletcher,et al. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas , 2017, The American journal of surgical pathology.
[6] M. Odenthal,et al. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas , 2016, Oncotarget.
[7] P. D. Dal Cin,et al. Analysis of MDM2 Amplification in 43 Endometrial Stromal Tumors: A Potential Diagnostic Pitfall , 2015, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[8] P. D. Dal Cin,et al. Targeted genomic analysis of Müllerian adenosarcoma , 2015, The Journal of pathology.
[9] B. Bjerkehagen,et al. Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22‐translocation , 2013, Genes, chromosomes & cancer.
[10] Jean-Yves Blay,et al. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. , 2012, The Lancet. Oncology.
[11] E. Tanner,et al. High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes. , 2012, Gynecologic oncology.
[12] M. van de Rijn,et al. The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor , 2012, The American journal of surgical pathology.
[13] Steven J. M. Jones,et al. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma , 2012, Proceedings of the National Academy of Sciences.
[14] E. Oliva,et al. Liposarcoma Arising in Uterine Lipoleiomyoma: A Report of 3 Cases and Review of the Literature , 2011, The American journal of surgical pathology.
[15] Louis Guillou,et al. MDM2 and CDK4 Immunostainings Are Useful Adjuncts in Diagnosing Well-Differentiated and Dedifferentiated Liposarcoma Subtypes: A Comparative Analysis of 559 Soft Tissue Neoplasms With Genetic Data , 2005, The American journal of surgical pathology.
[16] H. Denk,et al. Chromosomal alterations in low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma as detected by comparative genomic hybridization. , 2005, Gynecologic oncology.
[17] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[18] J. Sklar,et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] M. Birrer,et al. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. , 1997, Gynecologic oncology.
[20] N. Avgeropoulos,et al. Mesenchymal tumors , 2021, Epidemiology of Brain and Spinal Tumors.
[21] Stefan M. Pfister,et al. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions , 2019, Acta Neuropathologica.
[22] C. Antonescu,et al. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma , 2017, The American journal of surgical pathology.